Your browser doesn't support javascript.
loading
Programmed death-ligand 1 and tumor-infiltrating lymphocytes (TILs) - low TIL density may predict poorer long-term prognosis in T1 laryngeal cancer.
Pakkanen, Pihla; Ilmarinen, Taru; Halme, Elina; Irjala, Heikki; Koivunen, Petri; Pukkila, Matti; Ventelä, Sami; Almangush, Alhadi; Birkman, Eva-Maria; Lindgren, Outi; Pohjolainen, Virva; Sjöblom, Nelli; Haglund, Caj; Hagström, Jaana; Aaltonen, Leena-Maija.
Afiliación
  • Pakkanen P; Department of Otorhinolaryngology - Head and Neck Surgery, University of Helsinki and Helsinki University Hospital, Helsinki, Finland. pihla.pakkanen@helsinki.fi.
  • Ilmarinen T; Department of Otorhinolaryngology - Head and Neck Surgery, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Halme E; Department of Otorhinolaryngology - Head and Neck Surgery, University of Tampere and Tampere University Hospital, Tampere, Finland.
  • Irjala H; Department of Otorhinolaryngology - Head and Neck Surgery, University of Turku and Turku University Hospital, Turku, Finland.
  • Koivunen P; Department of Otorhinolaryngology - Head and Neck Surgery, University of Oulu and Oulu University Hospital, Oulu, Finland.
  • Pukkila M; Department of Otorhinolaryngology - Head and Neck Surgery, University of Eastern Finland and Kuopio University Hospital, Kuopio, Finland.
  • Ventelä S; Department of Otorhinolaryngology - Head and Neck Surgery, University of Turku and Turku University Hospital, Turku, Finland.
  • Almangush A; Department of Pathology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Birkman EM; Department of Pathology, University of Turku and Turku University Hospital, Turku, Finland.
  • Lindgren O; Department of Pathology, University of Oulu and Oulu University Hospital, Oulu, Finland.
  • Pohjolainen V; Fimlab Laboratories, Department of Pathology, Tampere University Hospital, Tampere, Finland.
  • Sjöblom N; Department of Pathology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Haglund C; Department of Pathology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Hagström J; Department of Surgery, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Aaltonen LM; Department of Pathology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Virchows Arch ; 2023 Jul 18.
Article en En | MEDLINE | ID: mdl-37462760
ABSTRACT
We evaluated the prognostic role of programmed death-ligand 1 (PD-L1) and tumor-infiltrating lymphocytes (TILs) in T1 glottic laryngeal squamous cell carcinoma (LSCC). T1 glottic LSCC patients (n = 174) treated at five Finnish university hospitals between 2003 and 2013 were included. Tissue microarray (TMA) blocks were used for PD-L1 immunohistochemistry. TILs were scored from intratumoral and stromal regions in whole tissue sections. Of 174 patients, 92 (53%) had negative, 66 (38%) intermediate, and 16 (9%) high PD-L1 levels. Of 80 patients whose TILs were analyzed, 50 (63%) had low and 30 (38%) high stromal TIL density. Patients with a local recurrence or a new primary tumor of the larynx had lower TIL density than had other patients (p = 0.047). High PD-L1 expression with low stromal TIL density was associated with inferior 5-year disease-specific survival (85% vs. 100%, p = 0.02). In conclusion, in patients treated for T1 glottic LSCC, low stromal TIL density was associated with local recurrences and new primary tumors of the larynx. High PD-L1 expression with low stromal TIL density may be associated with worse survival in T1 glottic LSCC.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Virchows Arch Asunto de la revista: BIOLOGIA MOLECULAR / PATOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Finlandia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Virchows Arch Asunto de la revista: BIOLOGIA MOLECULAR / PATOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Finlandia
...